How can drugs bypass the brain’s tightest security checkpoint? Researchers at the University of Eastern Finland discovered that hijacking the sodium-dependent multivitamin transporter (SMVT) allows creatine derivatives to cross the blood-brain barrier, offering hope for rare deficiency syndromes.
